Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

Atrial fibrillation (AF) is the most common sustained arrhythmia with a prevalence of up to 4% and an upwards trend due to demographic changes. It is associated with an increase in mortality and stroke incidences. While stroke risk can be significantly reduced through anticoagulant therapy, adequate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraft, Manuel, Büscher, Antonius, Wiedmann, Felix, L’hoste, Yannick, Haefeli, Walter E., Frey, Norbert, Katus, Hugo A., Schmidt, Constanze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058608/
https://www.ncbi.nlm.nih.gov/pubmed/33897427
http://dx.doi.org/10.3389/fphar.2021.638445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058608/
https://www.ncbi.nlm.nih.gov/pubmed/33897427
http://dx.doi.org/10.3389/fphar.2021.638445

Ejemplares similares